Jpmorgan Chase & CO Sonendo, Inc. Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.75 - $1.4 $25,553 - $47,699	-34,071 Reduced 13.39%	220,289 $165,000
Q2 2023 Aug 11, 2023	SELL	$1.06 - $2.01 $395,947 - $750,805	-373,535 Reduced 59.49%	254,360 $345,000
Q1 2023 May 11, 2023	BUY	$1.53 - $2.71 $396,395 - $702,112	259,082 Added 70.25%	627,895 $1.26 Million
Q4 2022 Feb 13, 2023	BUY	$1.11 - $2.9 $409,382 - $1.07 Million	368,813 New	368,813 $1.04 Million

9.27M

Ticker SONX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,661,200
Market Cap $2.48M
Description
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company a...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.